Chemomab Therapeutics Ltd.
For the period ended Dec 31, 2025. Filed Mar 23, 2026.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2025 · Filed Mar 23, 2026
Contents
ITEM 16B. CODE OF ETHICS
We have adopted a Code of Business Conduct and Ethics that includes provisions ranging from restrictions on gifts to conflicts of interest. All of our employees and directors are bound by this Code of Business Conduct and Ethics. Violations of our Code of Business Conduct and Ethics may be reported to the audit committee. The Code of Business Conduct and Ethics includes provisions applicable to all of our employees, including senior financial officers and members of our board of directors and is posted on our website. We intend to post amendments to or waivers from any such Code of Business Conduct and Ethics.
We granted no waivers under our Code of Ethics and Conduct in 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.